IL6 and hepatocellular carcinoma: In this context, the serine-threonine protein kinase (STK) 4 counteracts TLR signalling and concomitant IL-6 secretion through phosphorylation of the TLR downstream signalling molecular IRAK1 [73] and is therefore considered as tumour suppressor for HCC [74].